PMC:7381711 / 0-244 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T1","span":{"begin":0,"end":7},"obj":"Body_part"},{"id":"T2","span":{"begin":77,"end":84},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma82839"},{"id":"A2","pred":"fma_id","subj":"T2","obj":"http://purl.org/sig/ont/fma/fma82839"}],"text":"Heparin as a therapy for COVID-19: current evidence and future possibilities\nHEPARIN IN COVID-19\n\nAbstract\nCoronavirus disease 2019 (COVID-19), the clinical syndrome associated with infection by severe acute respiratory syndrome coronavirus 2 ("}

{"project":"LitCovid-PubTator","denotations":[{"id":"2","span":{"begin":0,"end":7},"obj":"Chemical"},{"id":"3","span":{"begin":25,"end":33},"obj":"Disease"},{"id":"24","span":{"begin":195,"end":242},"obj":"Species"},{"id":"33","span":{"begin":107,"end":131},"obj":"Disease"},{"id":"34","span":{"begin":133,"end":141},"obj":"Disease"},{"id":"35","span":{"begin":182,"end":191},"obj":"Disease"}],"attributes":[{"id":"A2","pred":"tao:has_database_id","subj":"2","obj":"MESH:D006493"},{"id":"A3","pred":"tao:has_database_id","subj":"3","obj":"MESH:C000657245"},{"id":"A24","pred":"tao:has_database_id","subj":"24","obj":"Tax:2697049"},{"id":"A33","pred":"tao:has_database_id","subj":"33","obj":"MESH:C000657245"},{"id":"A34","pred":"tao:has_database_id","subj":"34","obj":"MESH:C000657245"},{"id":"A35","pred":"tao:has_database_id","subj":"35","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Heparin as a therapy for COVID-19: current evidence and future possibilities\nHEPARIN IN COVID-19\n\nAbstract\nCoronavirus disease 2019 (COVID-19), the clinical syndrome associated with infection by severe acute respiratory syndrome coronavirus 2 ("}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T1","span":{"begin":25,"end":33},"obj":"Disease"},{"id":"T2","span":{"begin":88,"end":96},"obj":"Disease"},{"id":"T3","span":{"begin":107,"end":131},"obj":"Disease"},{"id":"T4","span":{"begin":133,"end":141},"obj":"Disease"},{"id":"T5","span":{"begin":182,"end":191},"obj":"Disease"},{"id":"T6","span":{"begin":195,"end":242},"obj":"Disease"},{"id":"T7","span":{"begin":195,"end":228},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A6","pred":"mondo_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A7","pred":"mondo_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Heparin as a therapy for COVID-19: current evidence and future possibilities\nHEPARIN IN COVID-19\n\nAbstract\nCoronavirus disease 2019 (COVID-19), the clinical syndrome associated with infection by severe acute respiratory syndrome coronavirus 2 ("}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T1","span":{"begin":11,"end":12},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Heparin as a therapy for COVID-19: current evidence and future possibilities\nHEPARIN IN COVID-19\n\nAbstract\nCoronavirus disease 2019 (COVID-19), the clinical syndrome associated with infection by severe acute respiratory syndrome coronavirus 2 ("}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T1","span":{"begin":0,"end":7},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_28304"}],"text":"Heparin as a therapy for COVID-19: current evidence and future possibilities\nHEPARIN IN COVID-19\n\nAbstract\nCoronavirus disease 2019 (COVID-19), the clinical syndrome associated with infection by severe acute respiratory syndrome coronavirus 2 ("}

{"project":"LitCovid-sentences","denotations":[{"id":"T1","span":{"begin":0,"end":76},"obj":"Sentence"},{"id":"T2","span":{"begin":77,"end":96},"obj":"Sentence"},{"id":"T3","span":{"begin":98,"end":106},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Heparin as a therapy for COVID-19: current evidence and future possibilities\nHEPARIN IN COVID-19\n\nAbstract\nCoronavirus disease 2019 (COVID-19), the clinical syndrome associated with infection by severe acute respiratory syndrome coronavirus 2 ("}